LINQ II™ ICM SYSTEM reveal linq™ mobile manager Exclusive app-based programmer thatsimplifies ICM procedure, enabling device activation, programming and CareLink™ pre-enrollment, all from your tablet. LINQ II™ INSERTABLE CARDIAC MONITOR World’smost accurate1-4ICMpersonalisedfor the patient’...
The LINQ II™ insertable cardiac monitor (ICM) with AccuRhythm™ AI algorithms is used for long-term heart monitoring.
LINQ II™ Insertable Cardiac Monitor LINQ II™ is a small, wireless insertable cardiac monitor (ICM) for patients with abnormal heart rhythms who experience infrequent symptoms, including dizziness, palpitations, syncope (fainting) and/or chest pain, thereby requiring long-term monitoring or ...
The Reveal LINQ™ ICM with AccuRhythm™ AI algorithms is for patients with infrequent symptoms requiring long-term cardiac monitoring.
To maximize AF detection, clinicians should monitor cryptogenic stroke/TIA patients with implantable cardiac monitors, starting as soon as possible. 8 Inform your clinical decisions with the LINQ family of ICMs Reveal LINQ™ ICM and LINQ II™ ICM ...
BackgroundThe Reveal LINQ™Insertable Cardiac Monitor (ICM) or Implantable Loop recorder (ILR), is a miniaturized, subcutaneous, single lead, electrocardiographic monitoring device which has been extensively used in the differential diagnosis of unexplained syncope and palpitations in adults.Annelise ...
Medtronic makes it simple to manage Reveal LINQ™ & LINQ II™ Insertable Cardiac Monitor (ICM) devices with the easy-to-use Reveal LINQ™ Mobile Manager. This app is downloaded to an iPad® tablet, and then paired via Bluetooth® to the Medtronic patient connector, which communicates...
Monitoring option Home monitor Home monitor and mobile app Patient symptom mark Patient assistant Mobile app or patient assistant Cardiac Compass ™Yes Yes MRI compatibility 1.5 and 3T 1.5 and 3T Clinician notification Nightly transmission/CareAlert ™ notifications Between 5–6 a.m. clinic ...
REVEAL DX. REVEAL XT, REVEAL LINQ INSERTABLE CARDIAC MONITOR产品名称,P890003 S305申请号,pma申请类型,Medtronic, Inc.申请人,数据来源于药智数据美国上市器械数据库。
Cardiac complications 2 2 (1.7) Allergic reaction 1 1 (0.8) Poor flow 1 1 (0.8) Arm edema 1 1 (0.8) Steal 1 1 (0.8) Reinterventions within the access circuit were performed in 7 of 120 patients at 3 months (5.8%) and 23 of 120 patients (19.2%) at 6 months (Table IV), accou...